An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females
Study Identifier
M12-673
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 1
Sex
Female
Age
18 - 40 Years
Protocol Summary
This is an open-label Phase 1 study in healthy premenopausal females evaluating the effects of different dosing regimens of elagolix on ovarian activity, ovulation, and ovarian reserve and to assess the effect of elagolix on selected endocrine/hormone levels.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 50805
Colorado Springs, Colorado, United States, 80910
Status
Not applicable
Location
Site Reference ID/Investigator# 51270
Colorado Springs, Colorado, United States, 80917
Status
Not applicable
Location
Site Reference ID/Investigator# 50884
Denver, Colorado, United States, 80246
Status
Not applicable
Location
Site Reference ID/Investigator# 50404
Lonetree, Colorado, United States, 80124
Status
Not applicable
Location
Site Reference ID/Investigator# 50904
Miami, Florida, United States, 33126
Status
Not applicable
Location
Site Reference ID/Investigator# 50402
South Miami, Florida, United States, 33143
Status
Not applicable
Showing {first} - {last} of {total} Results